Trial intelligence / Profile preview

Corticosteroid Nasal Irrigation as Early Treatment of Olfactory Dysfunction in COVID-19

TCTR20210714006Phase 3Recruiting

Sponsor
N/A
Start
Jul 2021
Countries
1
01

Overview

Phase 3, randomised trial in coronavirus disease 2019 (COVID-19) and Olfactory disorder (2 arms), sponsored by N/A. Started Jul 2021; status: recruiting.

02

Conditions

coronavirus disease 2019 (COVID-19)Olfactory disorder

Beyond the preview

Go deeper on TCTR20210714006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210714006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call